首页> 外文期刊>Applied Microbiology >Next Generation of Tn7-Based Single-Copy Insertion Elements for Use in Multi- and Pan-Drug-Resistant Strains of Acinetobacter baumannii
【24h】

Next Generation of Tn7-Based Single-Copy Insertion Elements for Use in Multi- and Pan-Drug-Resistant Strains of Acinetobacter baumannii

机译:下一代基于Tn7的单拷贝插入元件,用于鲍曼不动杆菌的多耐药和全耐药菌株

获取原文
           

摘要

The purpose of this study was to create single-copy gene expression systems for use in genomic manipulations of multidrug-resistant (MDR) and extensively drug-resistant (XDR) clinical isolates of Acinetobacter baumannii. In this study, mini-Tn7 vectors with zeocin and apramycin selection markers were created by cloning the ble and aac(3)-IV genes, respectively, enabling either inducible gene expression (pUC18T-mini-Tn7T-Zeo-LAC and pUC18T-mini-Tn7T-Apr-LAC) or expression from native or constitutive promoters (pUC18T-mini-Tn7T-Zeo and pUC18T-mini-Tn7T-Apr). The selection markers of these plasmids are contained within a Flp recombinase target (FRT) cassette, which can be used to obtain unmarked mini-Tn7 insertions upon introduction of a source of Flp recombinase. To this end, site-specific excision vectors pFLP2A and pFLP2Z (containing apramycin and zeocin selection markers, respectively) were created in this study as an accessory to the mini-Tn7 vectors described above. Combinations of these novel mini-Tn7 plasmids and their compatible pFLP2Z or pFLP2A accessory plasmid were used to generate unmarked insertions in MDR clinical isolates of A. baumannii. In addition, several fluorescent markers were cloned and inserted into MDR and XDR clinical isolates of A. baumannii via these apramycin and zeocin mini-Tn7 constructs to demonstrate their application.IMPORTANCEAcinetobacter baumannii is a high-priority pathogen for which research on mechanisms of resistance and virulence is a critical need. Commonly used antibiotic selection markers are not suitable for use in MDR and XDR isolates of A. baumannii due to the high antibiotic resistance of these isolates, which poses a barrier to the study of this pathogen. This study demonstrates the practical potential of using apramycin and zeocin mini-Tn7- and Flp recombinase-encoded constructs to carry out genomic manipulations in clinical isolates of A. baumannii displaying MDR and XDR phenotypes.
机译:这项研究的目的是创建单拷贝基因表达系统,用于鲍曼不动杆菌多药耐药(MDR)和广泛耐药(XDR)临床分离株的基因组操作。在这项研究中,分别通过克隆ble和aac(3)-IV基因来创建带有zeocin和阿普霉素选择标记的mini-Tn7载体,从而实现诱导型基因表达(pUC18T-mini-Tn7T-Zeo-LAC和pUC18T-mini -Tn7T-Apr-LAC)或天然或组成型启动子的表达(pUC18T-mini-Tn7T-Zeo和pUC18T-mini-Tn7T-Apr)。这些质粒的选择标记包含在Flp重组酶靶(FRT)盒中,可在导入Flp重组酶来源后用于获得未标记的mini-Tn7插入。为此,在这项研究中创建了位点特异性切除载体pFLP2A和pFLP2Z(分别包含阿普霉素和Zeocin选择标记)作为上述mini-Tn7载体的附件。这些新颖的mini-Tn7质粒及其兼容的pFLP2Z或pFLP2A辅助质粒的组合用于在鲍曼不动杆菌的MDR临床分离株中产生未标记的插入。此外,通过这些安普霉素和zeocin mini-Tn7构建体克隆了几种荧光标记并将其插入鲍曼不动杆菌的MDR和XDR临床分离株中,以证明其应用。毒力是关键需求。常用的抗生素选择标记不适用于鲍曼不动杆菌的MDR和XDR分离株,因为这些分离株具有很高的抗生素抗性,这对该病原体的研究构成了障碍。这项研究证明了使用阿普霉素和zeocin mini-Tn7和Flp重组酶编码的构建体在显示MDR和XDR表型的鲍曼不动杆菌临床分离株中进行基因组操作的实际潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号